Emirates News Agency on MSN23h
DoH introduces advanced gene-editing therapy for sickle cell disease, thalassemia for first time in UAE
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the introduction of CASGEVY, the first CRISPR/Cas9 gene-editing therapy in the UAE.
Scientific Research Publishing8h
Primary Male Neuroendocrine Breast Carcinoma: A Case Report and Review of Literature ()
Primary neuroendocrine carcinoma of the male breast is an exceptionally rare entity, with fewer than 50 cases documented in ...